Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Antengene Announces Financial Results for Full Year 2020

SHANGHAI and HONG KONG, March 26, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" or "the company", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in h...

2021-03-26 08:00 3324

Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion

WUHAN, China, March 26, 2021 /PRNewswire/ -- Chime Biologics, a China-based, world-class CDMO company, announced today that it has secured a total commitment ofUS$190 million investment from institutional investors, and over $100 million investment has already been closed today. This round of fin...

2021-03-26 08:00 3459

Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion

Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round

CINCINNATI, March 26, 2021 /PRNewswire/ -- Amplicore Inc., an early-stage biopharmaceutical company currently developing locally delivered and minimally invasive therapeutic solutions for musculoskeletal diseases, has successfully closed its Series Seed round of funding at$4 million. Investments ...

2021-03-26 05:19 2783

Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round

Antengene Appoints Kevin Lynch as Chief Medical Officer

SHANGHAI, China and MELBOURNE, Australia, March 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in ...

2021-03-25 23:26 3042

Antengene Appoints Kevin Lynch as Chief Medical Officer

Antengene Appoints Bo Shan as Chief Scientific Officer

SHANGHAI, March 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, announc...

2021-03-25 22:36 3183

Antengene Appoints Bo Shan as Chief Scientific Officer

CStone Pharmaceuticals Reports Financial Results and Business Highlights for Full-year 2020

SUZHOU, China, March 25, 2021 /PRNewswire/ -- CStone Pharmaceuticals (CStone, HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology therapies and precision medicines, today reported financial results and business highlights for the f...

2021-03-25 22:03 3863

SOPHiA GENETICS and Hitachi Announce Collaboration to Advance Data Driven Precision Medicine

Multi-year agreement to expand commercial footprint with world-leading genomics platform and develop R&D to unlock the potential of multimodal health data BOSTON, LAUSANNE, Switzerland and TOKYO, March 25, 2021 /PRNewswire/ -- SOPHiA GENETICS SA ("SOPHiA GENETICS"), pioneer in Data-Driven Medicin...

2021-03-25 21:00 4545

SOPHiA GENETICS and Hitachi Announce Collaboration to Advance Data Driven Precision Medicine

Össur Recognized by World Intellectual Property Organization (WIPO) as Leading Assistive Technology Development

REYKJAVIK, Iceland, March 25, 2021 /PRNewswire/ -- Össur (Nasdaq: OSSR), a global leader in the orthotics and prosthetics (O&P) industry with a rich history of ground-breaking innovations, has been recognized by the World Intellectual Property Organization (WIPO) for its intellectual property le...

2021-03-25 20:55 1591

China Eastern Flies Vaccines to Dominican Republic

SHANGHAI, March 25, 2021 /PRNewswire/ -- A new batch of vaccines developed by Chinese pharmaceutical companies Sinopharm and Sinovac was delivered onMarch 18 by China Eastern Airlines fromBeijing to the Dominican Republic, according to theShanghai-based airline.

2021-03-25 19:22 1506

China Eastern Flies Vaccines to Dominican Republic

BioNTech Chairman Helmut Jeggle joins the Board of IQM Quantum Computers

MUNICH, March 25, 2021 /PRNewswire/ -- IQM Quantum Computers (IQM) announced today that Helmut Jeggle has joined IQM´s board of directors. He joins the company during a transformational phase. After successfully closing its Series A funding round and selling its first q...

2021-03-25 18:29 2522

BioNTech Chairman Helmut Jeggle joins the Board of IQM Quantum Computers

111 Signs Strategic Cooperation Agreement with Jianming Pharmaceutical to Develop Chronic Disease Management Platform

SHANGHAI, March 25, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, and Jianming Pharmaceutical Group ("Jianming Pharmaceutical"), a p...

2021-03-25 17:00 2288

AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine

AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou,...

2021-03-25 17:00 2355

AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine

GenScript Signs a Strategic Partnership with the Theragen Etex and MedPACTO for Therapeutic Antibody Drug development

SINGAPORE, March 25, 2021 /PRNewswire/ -- A global leading biotech company GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) announced that the Company has entered into a strategic partnership with the Theragen Etex, a South Korea-based comprehensive pharmaceutical and biotechnology...

2021-03-25 16:35 3402

Positive Phase III Clinical Results for EirGenix's Proposed Trastuzumab Biosimilar

TAIPEI, March 24, 2021 /PRNewswire/ -- In a press conference today, EirGenix, Inc. (6589.TT) announced that the Phase III clinical trial (Trial No.: EGC002, NCT03433313) of its breast cancer biosimilar, EG12014 (proposed trastuzumab biosimilar, also called EGI014), has met its primary endpoint. E...

2021-03-24 23:27 2854

Ascentage Pharma's First Third-Generation BCR-ABL Inhibitor in China Olverembatinib (HQP1351) Recommended for Breakthrough Therapy Designation

SUZHOU, China and ROCKVILLE, Md., March 24, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Ev...

2021-03-24 19:07 1611

LimaCorporate And HSS Partner To Open First Provider-based Design And 3D Printing Center For Complex Joint Reconstruction Surgery

SAN DANIELE DEL FRIULI, Italy, March 24, 2021 /PRNewswire/ -- LimaCorporate S.p.A., (Lima) leading global orthopedics manufacturer, andHospital for Special Surgery (HSS), top-ranked in orthopedics for 11 consecutive years in the U.S., byU.S. New...

2021-03-24 16:00 1842

Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate

* Over 22,000 participants aged 18 years or older are expected to be enrolled in SPECTRA acrossLatin America, Asia, Europe and Africa * Interim analysis of the primary endpoint expected in the middle of 2021 CHENGDU, China and EMERYVILLE, Calif., March 24, 2021 /PRNewswire/ -- Clover Biopharm...

2021-03-24 14:18 2891

Forest Hills Lab is filing an IND to initiate a clinical phase 2 study on Parkinson's disease with the US FDA

HONG KONG, March 23, 2021 /PRNewswire/ -- Forest Hills Partners Hong Kong Limited (also known as Forest Hills Lab) is ready to file an Investigative New Drug (IND) application with the US FDA inApril 2021 to assess tolerability and efficacy with one of its drug candidates, namely FHL-301 in a pha...

2021-03-24 12:25 5107

Mindray Releases New Ceiling Supply Unit, Creating a More Optimized ICU Environment

SHENZHEN, China, March 24, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in developing and providing medical devices, has released a new series of ceiling supply units which exceeds ISO 11197-2019 standards. The HyPort R80 is the newest generation of bedside device management syste...

2021-03-24 11:49 1706

CStone Announces New Drug Approval of GAVRETO(R) (pralsetinib) as First Selective RET Inhibitor in China, Providing a New Therapy for a Subset of Non-Small Cell Lung Cancer Patients

* GAVRETO has been approved for the treatment of adults with locally advanced or metastatic RET fusion-positive non-small cell lung cancer after platinum-based chemotherapy * GAVRETO is the first approved selective RET inhibitor in China and first approved precision therapy for CStone SUZHOU,...

2021-03-24 10:46 4769

1 ... 406 407 408409410 411 412 ... 577